RP Bio Inc. (KOSDAQ: A314140)
Health Care · Pharmaceuticals · KR
₩5,910.00
+2.60% today · -16.4% 1Y
RP Bio Inc. (KOSDAQ: A314140) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $38.10M.
Over the last twelve months the share price has lost 16.4%, trading between 4.81K and 9.13K.
Tweenvest scores RP Bio Inc. across four factors: quality 70/100, value 74/100, growth 64/100. Its strongest factor is value.
A314140 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.10M
- Revenue (TTM)
- $91.32M
- P/E
- 7.60
- EPS
- 777.21
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- ₩9,130.00
- 52-week low
- ₩4,810.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.67M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Incannex Healthcare Inc.NasdaqCM: IXHL | $38.89M | $2.93 | -5.48% |
| Rekah Pharmaceutical Industry Ltd.TASE: REKA | $38.83M | ₪10.42 | -11.39% |
| Jin Yang Pharmaceutical Co., Ltd.KOSDAQ: A007370 | $38.36M | ₩3,995.00 | +0.50% |
| InnoPharmax Inc.TPEX: 4172 | $38.33M | NT$10.25 | -3.76% |
| Techno Drugs Ltd.DSE: TECHNODRUG | $38.05M | Tk35.50 | -13.83% |
| Planet 13 Holdings Inc.CNSX: PLTH | $37.60M | CA$0.16 | -15.79% |
| China Pharma Holdings, Inc.NYSEAM: CPHI | $37.45M | $0.83 | -4.86% |
| Impact BioMedical Inc.NYSEAM: IBO | $36.31M | $4.03 | -5.18% |
Figures last refreshed Oct 11, 2026.